Prebiotics could be used to battle neuropsychiatric disorders: Oxford study

By Annie Harrison-Dunn contact

- Last updated on GMT

Prebiotics to battle neuropsychiatric disorders: Oxford study

Related tags: Psychology, Immune system

Prebiotics may play a modulatory role in neuro-immuno processes and could reverse anxiety induced by inflammation, research in mice has suggested for the first time.

The University of Oxford research – backed by prebiotic supplier Clasado Biosciences – also suggested a beneficial effect of the non-digestible galacto-oligosaccharides on brain health and emotions via the immune system and a key serotonin receptor in the brain.

Serotonin is a brain neurotransmitter and about 90% of the body's serotonin is produced in the digestive tract. Conditions like depression and anxiety disorder are often treated with drugs that alter serotonin levels.

Previous research had suggested that altering intestinal microbiota with prebiotics and probiotics could reduce inflammatory response, alter brain chemistry and modulate anxiety behaviour in both rodents and humans.

However, the neuro-immune and behavioural effects of prebiotics on ‘sickness behaviour’ had not yet been explored. 

Writing in the journal Brain, Behavior and Immunity​, the Oxford researchers said: Our data suggest a potential role for prebiotics in the treatment of neuropsychiatric disorders where anxiety and neuroinflammation are prominent clinical features.”

The mice were fed the prebiotic for three weeks before being injected with lipopolysaccharide (LPS) to induce acute sickness behaviour and anxiety.

As expected this saw lower locomotor activity compared to the control group within the first six hours and acute inflammation leading to anxiety 24 hours later.

The researchers found that prebiotic-fed mice were significantly less anxious in the light-dark box 24 hours after the LPS injection. 

They also observed that elevated levels of the pro-inflammatory cytokine interleukin-1 beta seen in the control mice were not seen in the prebiotic-fed mice and there were further differences in the serotonin receptor 5-HT2A. Cortical interleukin-1 beta has been linked to brain trauma. 

Clasado CEO Graham Waters said the paper opened up new knowledge of the mechanisms underlying prebiotics’ potential within emotional and brain health.  

“We are hopeful that this research could lead to viable alternatives to existing pharmaceutical treatments targeted towards brain and psychological disorders,”​ he said in a release.

More than 350 million people worldwide suffer from depression, according to the World Health Organisation (WHO).

Source: Brain, Behavior and Immunity

Published online ahead of print, doi: 10.1016/j.bbi.2015.10.007

“Prebiotic administration normalizes lipopolysaccharide (LPS)-induced anxiety and cortical 5-HT2A receptor and IL1-β levels in male mice”

Authors: H.M. Savignac, Y. Couch, M. Stratford, D.M. Bannerman, G. Tzortzis, D.C. Anthony, P.W. Burnet 

Related news

Show more

Related products

show more

NZMP Probiotics Add Functionality to Juices

NZMP Probiotics Add Functionality to Juices

NZMP (Ingredients by Fonterra) | 17-May-2022 | Application Note

As consumers increasingly turn to functional beverages to address their health and wellness needs, juice brands can use probiotics to increase their appeal....

Nutraceuticals and the Genomic Revolution

Nutraceuticals and the Genomic Revolution

Nutra Biosystems - A Division of InVivo Biosystems | 05-May-2022 | Technical / White Paper

To meet growing demand for improving wellness, ingredient suppliers are increasingly using modern genomics to differentiate their product offerings and...

Related suppliers

Follow us

Products

View more

Webinars